# Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

> **NCT01019187** · PHASE2 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 226 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **PROCEDURE:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **OTHER:** Placebo
- **PROCEDURE:** Fatigue Assessment and Management
- **PROCEDURE:** Sleep Disorder Therapy
- **DRUG:** Armodafinil
- **PROCEDURE:** Quality-of-life assessment
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Fatigue Assessment and Management
- **PROCEDURE:** Management of Therapy
- **PROCEDURE:** Sleep disorder therapy
- **PROCEDURE:** cognitive assessment
- **PROCEDURE:** Quality of Life assessment
- **OTHER:** Questionnaire Administration
- **OTHER:** Placebo
- **PROCEDURE:** Fatigue assessment and management
- **PROCEDURE:** Management of therapy and complications
- **PROCEDURE:** Sleep disorder therapy
- **DRUG:** Armodafinil
- **PROCEDURE:** Cognitive Assessment

## Key facts

- **NCT ID:** NCT01019187
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-08
- **Final completion:** 2015-08
- **Target enrollment:** 226 (ESTIMATED)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019187, "Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01019187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*